Sirt5 KO induces increased lysine succinylation and decreased ATP synthase activity in mouse heart mitochondria. by Mengli Zhang (6331172)

Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells. by Xiaojuan Li (351842)

ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

Analysis of mitochondrial activity by the Seahorse extracellular flux analyzer. by Pierre Khalfi (7868252)

Subjects:

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

Growth kinetics of Measles viruses in Vero and THP-1 cell lines. by Pierre Khalfi (7868252)

Subjects:

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

Multiple miRNAs decrease telomerase activity. by Radmila Hrdličková (523455)

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

MtRNA binding to RIG-I, DNA mtDNA editing and context analysis. by Pierre Khalfi (7868252)

Subjects:

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

Comparison of estimated arterial cerebral blood volumes (aCBVs) (Mean ± SD^*) between multiphase bSSFP and AVAST (N = 5). by Ki Hwan Kim (427869)

AMPK phosphorylation and AC5 gene expression in hearts from sham and heart failure rats. by Anne Garnier (130125)

Subjects:

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”